Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Peest

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Praxis|August 14, 1998
[Prognostic factors and standard therapy of multiple myeloma]D Peest
Therapeutische Umschau. Revue Therapeutique|February 1, 1996
[Multiple myeloma]D Peest
Pathologie-Biologie|April 8, 1999
The role of alpha-interferon in multiple myelomaD Peest
Lancet (London, England)|January 7, 1989
Clonogenic myeloma cells and chemotherapyD Peest, H Deicher
Onkologie|February 1, 1988
[Induction and maintenance therapy in multiple myeloma. Results of a multicenter study]D Peest, H Deicher
Lancet (London, England)|February 19, 1994
Non-Hodgkin lymphoma in heart/lung transplant recipientsD Peest, H Deicher
Der Internist|October 26, 2007
[Therapy of multiple myeloma: indications and options]D Peest, A Ganser
Stem Cells (Dayton, Ohio)|August 1, 1995
Tumor-directed cytotoxicity in multiple myeloma--the basis for an experimental treatment approach with interleukin 2D Peest, R Leo, H Deicher
Leukemia Research|January 1, 1984
A plasma clot culture system for growing and antiproliferative drug sensitivity testing of myeloma stem cellsH Ludwig, E Fritz, D Peest
Der Internist|November 9, 2013
[Therapy of multiple myeloma. What is confirmed?]D Peest, A Ganser, H Einsele
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Praxis|August 14, 1998
[Prognostic factors and standard therapy of multiple myeloma]D Peest
Therapeutische Umschau. Revue Therapeutique|February 1, 1996
[Multiple myeloma]D Peest
Pathologie-Biologie|April 8, 1999
The role of alpha-interferon in multiple myelomaD Peest
Lancet (London, England)|January 7, 1989
Clonogenic myeloma cells and chemotherapyD Peest, H Deicher
Onkologie|February 1, 1988
[Induction and maintenance therapy in multiple myeloma. Results of a multicenter study]D Peest, H Deicher
Lancet (London, England)|February 19, 1994
Non-Hodgkin lymphoma in heart/lung transplant recipientsD Peest, H Deicher
Der Internist|October 26, 2007
[Therapy of multiple myeloma: indications and options]D Peest, A Ganser
Stem Cells (Dayton, Ohio)|August 1, 1995
Tumor-directed cytotoxicity in multiple myeloma--the basis for an experimental treatment approach with interleukin 2D Peest, R Leo, H Deicher
Leukemia Research|January 1, 1984
A plasma clot culture system for growing and antiproliferative drug sensitivity testing of myeloma stem cellsH Ludwig, E Fritz, D Peest
Der Internist|November 9, 2013
[Therapy of multiple myeloma. What is confirmed?]D Peest, A Ganser, H Einsele
Pageof 5